Skip to main content
SpringerLink
Log in

The Epidemiology of Lung Cancer

  • Chapter
Book cover Thoracic Oncology

Part of the book series: Cancer Treatment and Research ((CTAR,volume 105))

Abstract

Lung cancer continues to be the leader in cancer deaths in the United States. The incidence of lung cancer in men has slowly decreased since the late 1980s, but has just now begun to plateau in women at the end of this decade. Despite modest advances in chemotherapy for treating lung cancer, it remains a deadly disease with overall 5-yrsurvival rates having not increased significantly over the last 25 years, remaining at approximately 14%. Tobacco smoking causes approximately 85-90% of bronchogenic carcinoma. Environmental tobacco exposure or a second-hand smoke also may cause lung cancer in life-long non-smokers. Certain occupational agents such as arsenic,asbestos, chromium, nickel and vinyl chloride increase the relative risk for lung cancer.Smoking has an additive or multiplicative effect with some of these agents. Familial predisposition for lung cancer is an area with advancing research. Developments in molecular biology have led to growing interest in investigation of biological markers,which may increase predisposition to smoking-related carcinogenesis. Hopefully, in the future we will be able to screen for lung cancer by using specific biomarkers. Finally,dietary factors have also been proposed as potential risk modulators, with vitamins A, C and E proposed as having a protective effect. Despite the slow decline of smoking in the United States, lung cancer will likely continue its devastation for years to come.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Landis S, Murray T, Bolden S and Wingo P. Cancer statistics, 1999. CA Cancer J Clin 49:8–31, 1999.

    Article  PubMed  CAS  Google Scholar 

  2. National Center for Health Statistics: Public use data file documentation: Mortality data from ICD-9, 1995. Hyattsville, MD, Public Health Service, 1997.

    Google Scholar 

  3. Wingo P, Ries L, Rosenberg H, et al. Cancer incidence and mortality, 1973–1995: A report card for the US. Cancer 82:1197–1207, 1998.

    Article  PubMed  CAS  Google Scholar 

  4. National Cancer Institute: SEER Cancer Incidence Public-Use Database CD-ROM, 19731995, Bethesda MD, US Department of Health and Human Services, Public Health Service, 1998.

    Google Scholar 

  5. Baquet C, Horm J, Gibbs T et al. Socioeconomic factors and cancer incidence among blacks and whites. J NCI 83:551–557, 1991.

    CAS  Google Scholar 

  6. Wynder E. The past, present and future of the prevention of lung cancer. Cancer Epidemiology, Biomarkers and Prevention 7:735–48, 1998.

    CAS  Google Scholar 

  7. American Cancer Society. Tobacco Use. Trends in smoking, p.24, Cancer Facts and Figures, 1996. Atlanta: American Cancer Society, Inc. 1996.

    Google Scholar 

  8. Wagenknecht L, Cutter G, Haley N et al. Racial differences in serum cotinine levels among smokers in the coronary artery risk development in young adults study. Am J Public Health 80:1053, 1990.

    Article  PubMed  CAS  Google Scholar 

  9. Richie J, Carlemma S, Muscat J, et al. Differences in the urinary metabolites of the tobacco-specific lung carcinogen4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in black and white smokers. Cancer Epidemiol Biomark Prey 6:783–90, 1997.

    CAS  Google Scholar 

  10. Bach P, Cramer L, Warren J and Begg C. Racial differences in the treatment of early-stage lung cancer. New Engl J Med 341:1198–205, 1999.

    Article  PubMed  CAS  Google Scholar 

  11. Mahoney M and Michalek A. A meta-analysis of cancer incidence in United States and Canadian native populations. Int J Epidemiol 20:323–327, 1991.

    Article  PubMed  CAS  Google Scholar 

  12. Samet J, Wiggins C, Key C et al. Mortality from lung cancer and chronic obstructive pulmonary disease in New Mexico, 1958–82. Am J Public Health 78:1182–86, 1988.

    Article  PubMed  CAS  Google Scholar 

  13. American Cancer Society: Cancer facts and figures, California 1993. Oakland, CA, American Cancer Society, California Division, Inc., 1993.

    Google Scholar 

  14. Markides K, Coreil J and Ray L. Smoking among Mexican-Americans: a three generation study. Am J Public Health 77:708, 1987.

    Article  PubMed  CAS  Google Scholar 

  15. Marin G, Perez-Stable E, Marin B. Cigarette smoking among San Francisco Hispanics: the role of acculturation and gender. Am J Public Health 79:196, 1989.

    Article  PubMed  CAS  Google Scholar 

  16. U.S. Department of Health and Human Services (DHHS). The health consequences of smoking for women. Washington, DC: DHHS. Public Health Service, Office of the Assistant Secretary for Health, Office on Smoking and Health, 1980.

    Google Scholar 

  17. Samet J, Skipper B, Humble C, et al. Lung cancer risk and vitamin A consumption in New Mexico. Am Rev Respir Dis 131:198–202, 1985.

    PubMed  CAS  Google Scholar 

  18. Garfinkel L and Stellman S. Smoking and lung cancer in women: Findings in a prospective study. Cancer Res 48:6951, 1988.

    CAS  Google Scholar 

  19. Samet J, Wiggins C, Humble C et al. Cigarette smoking and lung cancer in New Mexico. Am Rev Respir Dis 137:1110–1113, 1998.

    Google Scholar 

  20. Kubat G. Aspects of the epidemiology of lung cancer in smokers and nonsmokers in the United States. Lung Cancer 15:1–20, 1996.

    Article  Google Scholar 

  21. Brownson R, Alavanja M, Caporaso N et al. Epidemiology and prevention of lung cancer in nonsmokers. Epidemiologic Reviews 20:218–236, 1998.

    Article  PubMed  CAS  Google Scholar 

  22. Redmond W. Trends in adolescent cigarette use: The diffusion of daily smoking. J of Behavioral Medicine 22(4):379–95, 1999.

    Article  CAS  Google Scholar 

  23. Kreuzer M, Kreienbroch L, Gerken M et al. Risk factors for lung cancer in young adults. Am J of Epidemiol 147:1028–1037, 1998.

    Article  CAS  Google Scholar 

  24. Bourke W, Milstein D, Giura R et al. Lung cancer in young adults. Chest 102:1723–9, 1992.

    Article  PubMed  CAS  Google Scholar 

  25. Rocha M, Fraire A, Guntupalli K et al. Lung cancer in the young. Cancer Detect Prey 18:349–55, 1994.

    CAS  Google Scholar 

  26. Sekine I, Nishiwaki Y, Yokose T et al. Young lung cancer patients in Japan: Different characteristics between the sexes. Ann Thorac Surg 67:1451–55, 1999.

    Article  PubMed  CAS  Google Scholar 

  27. Wu-Williams A, Dai X, Blot W et al. Lung cancer among women in north-east China. Br J Cancer 1990;62:982–7, 1990.

    Article  PubMed  CAS  Google Scholar 

  28. Hirayama T. Life-style and mortality. A large-scale census-based cohort study in Japan. In: J. Wahrendorf (ed.), Contributions to Epidemiology and Biostatistics. Vol. 1,1–133. Basel: S. Karger AG, 1993.

    Google Scholar 

  29. The female smoker: From addiction to recovery. Christen J and Christen A. Creative Services, Indiana University School of Medicine, Indianapolis, IN, 1998.

    Google Scholar 

  30. Wynder E and Graham E. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma. A study of six hundred and eighty-four proved cases. JAMA 143:329–336, 1950.

    Article  CAS  Google Scholar 

  31. Doll R and Hill A. Smoking and carcinoma of the lung. Preliminary report. Br Med J 2:739–748, 1950.

    Article  PubMed  CAS  Google Scholar 

  32. Wynder E and Hoffman D. A study in tobacco carcinogenesis. VII. The role of higher polycyclic hydrocarbons. Cancer (Phila.) 12:1079–86, 1959.

    Article  CAS  Google Scholar 

  33. Wynder E, Hoffman D. Tobacco and tobacco smoke: studies in experimental carcinogenesis. New York, Academic Press, 1967.

    Google Scholar 

  34. US Public Health Service: Smoking and Health. A Report on the Advisory Committee to the Surgeon General of the Public Health Service. US Department of Health, Education and Welfare, Center for Disease Control, 1964.

    Google Scholar 

  35. US Public Health Service: Smoking and Health. A Report of the Surgeon General. Rockville, Maryland, US Department of Health, Education, and Welfare, Public Health Service, Office on Smoking and Health, 1979.

    Google Scholar 

  36. Doll R and Peto R. Mortality in relation to smoking: 20 years= observations on male British doctors. Br Med J 2:1525, 1976.

    Article  PubMed  CAS  Google Scholar 

  37. Rogot E and Murray J. Smoking and causes of death among US veterans: 16 years of observation. Public Health Rep 15:213, 1980.

    Google Scholar 

  38. US Department of Health and Human Services: Smoking and health in the Americas. Atlanta, US Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1992; DHHS Publication No. [CDC] 92–8419.

    Google Scholar 

  39. Doll R and Peto R. Cigarette smoking and bronchial carcinoma: Dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health 32:303–313, 1978.

    Article  PubMed  CAS  Google Scholar 

  40. Stellman S and Garfinkel L Lung cancer risk is proportional to cigarette tar yield: evidence from a prospective study. Prey Med 18:518, 1989.

    Article  CAS  Google Scholar 

  41. Lubin J, Blot W, Berrino F et al. Patterns of lung cancer risk according to type of cigarette smoked. Int J Cancer 33:569–576, 1984.

    Article  PubMed  CAS  Google Scholar 

  42. United States Department of Health and Human Services. Strategies to control tobacco use in the United States. Smoking Tobacco Control Monogr (NIH) 1:1–307, 1991.

    Google Scholar 

  43. Cummings K, Giovino G and Mendicino A. Cigarette advertising and black-white differences in brand preference. Public Health Rep 102:698–701, 1987.

    PubMed  CAS  Google Scholar 

  44. Kabat G and Hebert J. Use of mentholated cigarettes and lung cancer risk. Cancer Res 51:6510–6513, 1991.

    PubMed  CAS  Google Scholar 

  45. Redmond W. Trends in adolescent cigarette use: The diffusion of daily smoking. J of Behavioral Med 22(4):379–95, 1999.

    Article  CAS  Google Scholar 

  46. Damber L and Larsson L. Smoking and lung cancer with special regard to type of smoking and type of cancer: a case-control study in north Sweden. Br J Cancer 53:673, 1986.

    Article  PubMed  CAS  Google Scholar 

  47. Satcher D. Cigars and public health. NEJM 340(23):1829–31, 1999.

    Article  PubMed  CAS  Google Scholar 

  48. Barsky S, Roth M, Kleerup E et al. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine and/or tobacco. J of the Natl Cancer Inst 90:1198–1205, 1998.

    Article  CAS  Google Scholar 

  49. Becher H, Jockel K, Timm J et al. Smoking cessation and nonsmoking intervals: Effect of different smoking patterns on lung cancer risk. Cancer Causes and Control 2:38187, 1991.

    Google Scholar 

  50. US Department of Health and Human Services: The Health Benefits of Smoking Cessation: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. DHHS Publication No. (CDC) 90–8416, 1990.

    Google Scholar 

  51. Higgins I and Wynder E. Reduction in risk of lung cancer among ex-smokers with particular reference to histologic type. Cancer 62:2397–2401, 1988.

    Article  PubMed  CAS  Google Scholar 

  52. US Surgeon General. The health consequences of involuntary smoking. Washington, DC, United States Department of Health and Human Services, Centers for Disease Control, Publication No. 87–8398,1986.

    Google Scholar 

  53. Committee on Passive Smoking, Board on Environmental Studies and Toxicology, National Research Council: Environmental Tobacco Smoke: Measuring Exposures and Assessing Health Effects. Washington, DC, National Academy Press, 1986.

    Google Scholar 

  54. US Environmental Protection Agency: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children. EPA Publication No. 600/690/006A.

    Google Scholar 

  55. Hammond S. Exposure of US workers to environmental tobacco smoke. Environ Health Perspect 107(Suppl 2):329–340, 1999.

    Article  PubMed  Google Scholar 

  56. NIOSH: Current Intelligence bulletin 54. Environmental tobacco smoke in the workplace. Lung cancer and other health effects. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, Cincinnati, 1991.

    Google Scholar 

  57. Boffetta P, Agudo A, Ahrens W et al. Multicenter case-control study of exposure to enviromental tobacco smoke and lung cancer in Europe. J of the Natl Cancer Inst 90:144050, 1998.

    Google Scholar 

  58. Chapman S, Borland R, Scollo M et al. The impact of smoke-free workplaces on declining cigarette consumption in Australia and the United States. Am J of Public Health 89:10181023, 1999.

    Google Scholar 

  59. Saccomanno G, Huth G, Auerbach O et al. Relationship of radioactive radon daughters and cigarette smoking in the genesis of lung cancer in uranium miners. Cancer 62:1402–1408, 1988.

    Article  PubMed  CAS  Google Scholar 

  60. Oge, M. Radon risk in the home. Science 255:1194, 1992.

    PubMed  CAS  Google Scholar 

  61. Samet J. Radon and lung cancer. J Natl Cancer Inst 81:745–757, 1989.

    Article  PubMed  CAS  Google Scholar 

  62. American Medical Association Council of Scientific Affairs: Health Effects of radon exposure. Arch Intern Med 151:674–77, 1991.

    Article  Google Scholar 

  63. Samet J, Stolwijk J, Rose S. Summary.International Workshop on Residential Radon Epidemiology. Health Physics 60:223–227, 1991.

    Article  PubMed  CAS  Google Scholar 

  64. Samet J and Hornung R. Review of radon and lung cancer risk. Risk Analysis 10:65–75, 1990.

    Article  PubMed  CAS  Google Scholar 

  65. U.S. Environmental Protection Agency. Cancer risk from outdoor exposure to air toxins, Vol. 1, final report. Research Triangle Park, NC: Environmental Criteria and Assessment Office, EPA/450/1–90/004A, 1990.

    Google Scholar 

  66. Natusch D. Potentially carcinogenic species emitted to the atmosphere by fossil-fueled power plants. Environ Health Perspect 22:79–90, 1978.

    Article  PubMed  CAS  Google Scholar 

  67. Robinette C, Silverman C and Jablon S. Effects upon health of occupational exposure to microwave radiation (radar). Am J Epidemiol 112:39–53, 1980.

    PubMed  CAS  Google Scholar 

  68. Vogero D, Ahlbom A, Olin R et al. Cancer morbidity among workers in the telecommunications industry. Br J of Ind Med 42:191–195, 1985.

    Google Scholar 

  69. Steenland K. Lung cancer and diesel exhaust: A review. Am J Ind Med 10:177–189, 1986.

    PubMed  CAS  Google Scholar 

  70. Lipsett M and Campleman S. Occupational exposure to diesel exhaust and lung cancer: A meta-analysis. Am J Public Health 89:1009–17, 1999.

    Article  PubMed  CAS  Google Scholar 

  71. Samet J and Lerchen M. Proportion of lung cancer caused by occupation: a critical review. In: Gee J, Morgan W and Brooks S, eds. Occupational lung disease. New York, Raven Press: 55, 1984.

    Google Scholar 

  72. Nelson D Emont S, Brackbill R et al. Cigarette smoking prevalence by occupation in the United States: a comparison between 1978 to 1980 and 1987 to 1990. J Occup Med 36:516–525, 1994.

    PubMed  CAS  Google Scholar 

  73. Selikoff I, Hammond E and Churg J. Asbestos exposure, smoking andneoplasia. JAMA 204:104, 1968.

    Article  Google Scholar 

  74. International Agency for Research on Cancer (IARC). IARC monographs on the evaluation of carcinogenic risks to humans. Overall evaluations of carcino-genicity: an updating of IARC monographs volumes 1 to 42 (Suppl 7). Lyon: IARC, 1987.

    Google Scholar 

  75. Health and Safety Commission: Asbestos. Vol. 2: Papers Prepared for the Advisory Committee. London, Her Majesty’s Stationery Office, pp. 8–55, 1979.

    Google Scholar 

  76. Weiss W. Lobe of origin in the attribution of lung cancer to asbestos. Br J of Ind Med 45:544–547, 1986.

    Google Scholar 

  77. Steenland K, Loomis D, Shy C and Simonsen N. Review of occupational lung carcinogens. Am J of Ind Med 29:474–490, 1996.

    Article  CAS  Google Scholar 

  78. Weiss W. Asbestosis: A marker for the increased risk of lung cancer among workers exposed to asbestos. Chest 115:536–549, 1999.

    Article  PubMed  CAS  Google Scholar 

  79. Hammond E, Selikoff I and Seidman H. Asbestos exposure, cigarette smoking and death rates. Ann NY Acad Sci 330:473–90, 1979.

    Article  PubMed  CAS  Google Scholar 

  80. Browne K. A threshold for asbestos related lung cancer. Br J Ind Med 43:556–58, 1986.

    PubMed  CAS  Google Scholar 

  81. Liddell F. Latent periods in lung cancer mortality in relation to asbestos dose and smoking. In: Wagner J and Davis W, eds, Biological Effects of Mineral Fibres, Lyon, IARC, pp. 661–665, 1980.

    Google Scholar 

  82. Enterline P, Marsh G, Esmen N et al. Some effects of cigarette smoking, arsenic and SO, on mortality among US copper smelter workers. J Occup Med 29:831–38, 1987.

    PubMed  CAS  Google Scholar 

  83. Pershagen G, Wall S, Taube A et al. On the interaction between occupational arsenic exposure and smoking and its relationship to lung cancer. Scand J Work Environ Health 7:302–09, 1981.

    Article  PubMed  CAS  Google Scholar 

  84. Brown C and Chu K. Implications of the multistage theory of carcinogenesis applied:o occupational arsenic exposure. J Natl Cancer Inst 70:455–63, 1983.

    PubMed  CAS  Google Scholar 

  85. Sobel W, Bond G, Baldwin C et al. An update of respiratory cancer and occupational exposure to arsenicals. Am J Ind Med 13:263–70, 1988.

    Article  PubMed  CAS  Google Scholar 

  86. McCallum R, Woolley V and Petrie A. Lung cancer associated with chloromethyl methyl ether manufacture: An investigation at two factories in the United Kingdom. Br J Ind Med 40:384–89, 1983.

    PubMed  CAS  Google Scholar 

  87. Weiss W, Moser R and Auerbach O. Lung cancer in chloromethyl ether workers. Am Rev Respir Dis 120:1031–37, 1979.

    PubMed  CAS  Google Scholar 

  88. Hayes R, Sheffet A and Spirtas R. Cancer mortality among a cohort of chromium pigment workers. Am J Ind Med 16:127–33, 1989.

    Article  PubMed  CAS  Google Scholar 

  89. Doll R, Mathews J, and Morgan L. Cancers of the lung and nasal sinuses in nickel workers: A reassessment of the period of risk. Br J Ind Med 34:102–05, 1977.

    PubMed  CAS  Google Scholar 

  90. International Committee on Nickel Carcinogenesis in Man. Report of the International Committee on Nickel Carcinogenesis in Man. Scand J Work Environ Health 16:1–82, 1990.

    Article  Google Scholar 

  91. Simonato L, L’Abbe K, Andersen A et al. A collaborative study of cancer incidence and mortality among vinyl chloride workers. Scand J Work Environ Health 17:159–69, 1991.

    Article  PubMed  CAS  Google Scholar 

  92. International Agency for Research on Cancer (IARC). IARC monographs on the evaluation of carcinogenic risk of chemicals to humans. Polynuclear aromatic hydrocarbons, part 1, chemical, environmental and experimental data. Lyon: IARC, 32, 1983.

    Google Scholar 

  93. Lloyd J. Long-term mortality study of steelworkers. Respiratory cancer in coke plant workers. J Occup Med 13:53–68, 1971.

    Article  PubMed  CAS  Google Scholar 

  94. Steenland K and Ward E. Lung cancer incidence among patients with beryllium disease: a cohort mortality study. J Natl Cancer Inst 83:1380–85, 1991.

    Article  PubMed  CAS  Google Scholar 

  95. MacMahon B. The epidemiological evidence on the carcinogenicity of beryllium in humans. J Occup Med 36:15–26, 1994.

    PubMed  CAS  Google Scholar 

  96. Lamm S, Parkinson M, Anderson M and Taylor W. Determinants of lung cancer risk among cadmium-exposed workers. Ann Epidemiol 2:195–211, 1992.

    Article  PubMed  CAS  Google Scholar 

  97. Thun M, Schnorr T, Smith A et al. Mortality among a cohort of US cadmium production workers B An update. J Natl Cancer Inst 74:235–33, 1985.

    Google Scholar 

  98. Marsh G, Stone R and Henderson V. A reanalysis of the National Cancer Institute study on lung cancer mortality among industrial worker exposed to formaldehyde. J Occup Med 34:42–44, 1992.

    PubMed  CAS  Google Scholar 

  99. U.S. Environmental Protection Agency. Health assessment document for acetaldehyde. Research Triangle Park, NC: Office of Health and Environmental Assessment. 1987: EPA/600/8–86/015A.

    Google Scholar 

  100. International Agency for Research on Cancer (IARC). IARC monographs on the evaluation of carcinogenic risks to humans. Chromium, nickel and welding fumes. Lyon: IARC 49:447–525, 1990.

    Google Scholar 

  101. Miettinen O and Rossiter C. Man-made mineral fibers and lung cancer: epidemiologic evidence regarding the causal hypothesis. Scand J Work Environ Health 16:221–231, 1990.

    Article  PubMed  CAS  Google Scholar 

  102. Saffiotti U. Lung cancer induction by crystalline silica. Prog Clin Biol Res 374:51–69, 1992.

    PubMed  CAS  Google Scholar 

  103. Simonato L, Fletcher A, Saracci R and Thomas T. Occupational exposure to silica and cancer risk. IARC Sci Publ 97:55–64, 1990.

    PubMed  Google Scholar 

  104. Wu A, Fontham E, Reynolds Pet al. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 141:1023–32, 1995.

    PubMed  CAS  Google Scholar 

  105. Zheng W, Blot W, Liao M et al. Lung cancer and prior tuberculosis infection in Shanghai. Br J Cancer 56:501, 1987.

    Article  PubMed  CAS  Google Scholar 

  106. Henschke C, McCauley D, Yankelevitz D et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 354:99–105, 1999.

    Article  PubMed  CAS  Google Scholar 

  107. Turner-Warwich M, Lebowitz M, Burrows B and Johnson A. Cryptogenic fibrosing alveolitis and lung cancer. Thorax 35:496–99, 1980.

    Article  Google Scholar 

  108. Sellers T, Bailey-Wilson J, Elston R et al. Evidence for Mendelian inheritance in the pathogenesis of lung cancer. J Natl Cancer Inst 82:1272, 1990.

    Article  PubMed  CAS  Google Scholar 

  109. Samet J, Humble C and Pathak D. Personal and family history of respiratory disease and lung cancer risk. Am Rev Resp Dis 134:466, 1986.

    PubMed  CAS  Google Scholar 

  110. Osann K. Lung cancer in women: The importance of smoking, family history of cancer and medical history of respiratory disease. Cancer Res 51:4893–97, 1989.

    Google Scholar 

  111. Tokuhata G and Lilienfeld A. Familial aggregation of lung cancer in humans. J Natl Cancer Inst 30:289–312, 1963.

    PubMed  CAS  Google Scholar 

  112. Fain P, Lynch H, Albano et al. Sex differences in lung cancer incidence: A genetic model. Med Hypoth 7:1109–1112, 1981.

    Article  CAS  Google Scholar 

  113. Perera F and Weinstein I. Molecular epidemiology and carcinogen DNA adduct detection: New approaches to studies of human cancer causation. J Chron Dis 35:581–600, 1982.

    Article  PubMed  CAS  Google Scholar 

  114. Harris C. Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair. Carcinogenesis 10:1563–66, 1989.

    Article  PubMed  CAS  Google Scholar 

  115. Glickman B. DNA repair and its relationship to the origins of human cancer. In: Cleton F and Simons J (eds), Genetic origin of tumor cells. Nijhoff, The Hague, 25–51, 1980.

    Chapter  Google Scholar 

  116. Phillips D, Hewer A, Matin C et al. Correlation of DNA adduct levels in human lung with cigarette smoking. Nature 336:790–92, 1982.

    Article  Google Scholar 

  117. Strong L and Amos C. Inherited susceptibility. In: Schottenfeld D and Fraumeni J (eds). Cancer epidemiology and prevention. Oxford University Press, New York, 559–583,1996.

    Google Scholar 

  118. Nakachi K, Imai K, Hayashi S et al. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 51:5177–80, 1991.

    PubMed  CAS  Google Scholar 

  119. Meyer U, Zanger U, Zanger D et al. Genetic polymorphisms of drug metabolism. Adv Drug Res 19:197–241, 1990.

    CAS  Google Scholar 

  120. Caporaso N, Tucker M, Hoover R et al. Lung cancer and the debrisoquine metabolic phenotype. J Natl Cancer Inst 82:1264–72, 1990.

    Article  PubMed  CAS  Google Scholar 

  121. Crespi C, Penman B, Gelboin H et al. A tobacco smoke-derived nitrosamine, 4(methylnitrosamino)-1-(3-pyridy1)-1-butanone, is activated by multiple human cytochrome P450=s including the polymorphic human cytochrome P4502D6. Carcinogenesis 11:1293–1300, 1990.

    Article  PubMed  CAS  Google Scholar 

  122. Caporaso N, Tucker M, Hoover R et al. Lung cancer and the debrisoquine metabolic phenotype. J Natl Cancer Inst 82:1264–72, 1990.

    Article  PubMed  CAS  Google Scholar 

  123. Pianezza M, Sellers E and Tyndale R. Nicotine metabolism defect reduces smoking. Nature 393:750, 1998.

    Article  PubMed  CAS  Google Scholar 

  124. London S, Idle J, Daly A and Coetzee G. Genetic variation of CYP2A6, smoking, and risk of cancer. Lancet 353:898–899, 1999.

    Article  PubMed  CAS  Google Scholar 

  125. Seidegard J, Pero R, Miller D et al. Glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 751–53, 1986.

    Google Scholar 

  126. Nazar-Stewart V, Motulsky A, Eaton D et al. The glutathione S-transferase polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 53:2313, 1993.

    PubMed  CAS  Google Scholar 

  127. Wiencke J, Kelsey K, Lamela R et al. Human glutathione-S-transferase deficiency as a marker of susceptibility to epoxide-induced cytogenetic damage. Cancer Res 50:1585–90, 1990.

    PubMed  CAS  Google Scholar 

  128. Bennett W, Alavanja M, Blomeke B et al. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J Natl Cancer Inst 91:2009–14, 1999.

    Article  PubMed  CAS  Google Scholar 

  129. Rodenhuis S and Slebus R. The RAS oncogene in human lung cancer. Am Rev Resp Dis 142:527–30, 1990.

    Google Scholar 

  130. Nelson H, Christiani D, Mark E et al. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst 91:2032–38, 1999.

    Article  PubMed  CAS  Google Scholar 

  131. Minna J, Battey J, Brooks B et a1. Molecular genetic analysis reveals chromosomal deletion, gene amplification, and autocrine growth factor production in the pathogenesis of human lung cancer. Cold Spring Harbor Symp Quant Bio151: 843–53, 1986.

    Google Scholar 

  132. Funa K, Steinholz L, Nou et al. Increased expression ofN-mycin human small cell lung cancer biopsies predicts lack of response to chemotherapy and poor prognosis. Am J Clin Pathol 88:216–20, 1987.

    PubMed  CAS  Google Scholar 

  133. Johnson B, Ihde D, Makuch R et al.mycfamily oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical course. J Clin Invest 79:1629–34, 1987.

    Article  PubMed  CAS  Google Scholar 

  134. Hendler F and Ozanne B. Human squamous cell lung cancers express increased epidermal growth factor receptor. J Clin Invest 74:647–51, 1984.

    Article  PubMed  CAS  Google Scholar 

  135. Schneider P, Hung M, Chiocca S, et al. Differential expression of the c-erbB-2 gene in human small cell and non-small lung cancer. Cancer Res 49:4968–71, 1989.

    PubMed  CAS  Google Scholar 

  136. Kern F, Schwartz D, Nordberg J, et al. p185 l’eu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res 50:5184–91, 1990.

    PubMed  CAS  Google Scholar 

  137. Takashi T, Nau M, and Chiba I. p53: A frequent target for genetic abnormalities in lung cancer. Science 246:491–94, 1989.

    Article  Google Scholar 

  138. Harbor J, Sali S, Whang-Peng J, et al. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241:353–57, 1988.

    Article  Google Scholar 

  139. Peto R, Doll R, Buckley J et al. Can dietary beta-carotene materially reduce human cancer rates? Nature 290:201–208, 1981.

    Article  PubMed  CAS  Google Scholar 

  140. Shekelle R, Liu S, Raynor W, et al. Dietary vitamin A and risk of cancer in the Western Electric Study. Lancet 2:1185–90, 1981.

    Article  PubMed  CAS  Google Scholar 

  141. Byers T, Graham S, Haughey B et al. Diet and lung cancer risk: Findings from the western New York diet study. Am J Epidemiol 125:351–63, 1987.

    PubMed  CAS  Google Scholar 

  142. Stryker W, Kaplan L, Stein E, et al. The relation of diet, cigarette smoking and alcohol consumption to beta-carotene and alpha-tocopherol levels. Am J Epidemiol 127:283–96, 1988.

    PubMed  CAS  Google Scholar 

  143. Chow C. Dietary vitamin E and cellular susceptibility to cigarette smoke. Ann NY Acad Sci 393:426–36, 1982.

    CAS  Google Scholar 

  144. Menkes M, Comstock G, Vuilleumeir J et al. Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J of Med 315:1250–54, 1986.

    Article  CAS  Google Scholar 

  145. Willett W, Polk B, Underwood B et al. Relation of serum vitamins A and E and carotenoids to the risk of cancer. N Engl J Med 310:430–34, 1984.

    CAS  Google Scholar 

  146. Yong L, Brown C, Schatzkin A, et al. Intake of vitamins E, C and A and risk of lung cancer. The NHANES I epidemiologic followup study. Am J of Epidemiol 146:231–43, 1997.

    Article  CAS  Google Scholar 

  147. Omenn G, Goodman G, Thonquist et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150–5, 1996.

    Article  PubMed  CAS  Google Scholar 

  148. Knekt P, Jarvinen R, Seppanen R, et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J of Epidemiol 146:223–30, 1997.

    Article  CAS  Google Scholar 

  149. Vierod M, Laake P and Thelle D. Dietary fat intake and risk of lung cancer: a prospective study of 51,452 Norwegian men and women. Eur J of Cancer Prevention 6:540–49, 1997.

    Article  Google Scholar 

  150. Knekt P, Seppanen R, Jarvinen R et al. Dietary cholesterol, fatty acids and the risk of lung cancer among men. Nutr Cancer 16:267–75, 1991.

    Article  PubMed  CAS  Google Scholar 

  151. Salonen J, Alfthan G, Huttenen J et al. Association between serum selenium and risk of cancer. Am J Epidemiol 120:342–49, 1984.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Indiana University School of Medicine, Indianapolis, IN, 46202, USA

    M.D. Mark D. Williams

  2. Vanderbilt University Medical Center, Nashville, TN, 37232, USA

    M.D. Alan B. Sandler

Authors
  1. M.D. Mark D. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M.D. Alan B. Sandler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Johns Hopkins Oncology Center, Bunting Blaustein Cancer Research Building, Baltimore, Maryland, USA

    David S. Ettinger MD

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Williams, M.D., Sandler, A.B. (2001). The Epidemiology of Lung Cancer. In: Ettinger, D.S. (eds) Thoracic Oncology. Cancer Treatment and Research, vol 105. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1589-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1589-0_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5629-5

  • Online ISBN: 978-1-4615-1589-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation